- ►annals.org NS Young - Annals of Internal Medicine, 2002 - Am Coll Physicians In aplastic anemia, hematopoiesis fails: Blood cell counts are extremely low,
and the bone marrow appears empty. The pathophysiology of aplastic anemia is now
believed to be immune-mediated, with active destruction of blood-forming ... Cited by 239 - Related articles - BL Direct - All 15 versions
- ►hematologylibrary.org NS Young, RT Calado, P Scheinberg - Blood, 2006 - bloodjournal.hematologylibrary.org Aplastic anemia, an unusual hematologic disease, is the paradigm of the human
bone marrow failure syndromes. Almost universally fatal just a few decades ago,
aplastic anemia can now be cured or ameliorated by stem-cell ... Cited by 137 - Related articles - BL Direct - All 12 versions
S Rosenfeld, D Follmann, O Nunez, NS … - Jama, 2003 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context In most patients, ... Cited by 120 - Related articles - BL Direct - All 4 versions
M Petri, RJ Jones, RA Brodsky - Arthritis and rheumatism, 2003 - assets0.pubget.com Objective. High-dose chemotherapy followed by hematopoietic stem cell
transplantation is increasingly being studied as a treatment for severe
autoimmune disorders, such as systemic lupus erythematosus (SLE). High-dose ... Cited by 105 - Related articles - View as HTML - BL Direct - All 5 versions
JCW Marsh, SE Ball, P Darbyshire, EC … - British journal of haematology, 2003 - cat.inist.fr Guidelines for the diagnosis and management of acquired aplastic anaemia.
JCW MARSH, SE BALL, P DARBYSHIRE, EC GORDON-SMITH, AJ KEIDAN ... Cited by 92 - Related articles - BL Direct - All 3 versions
DB Drachman, RJ Jones, RA Brodsky - Annals of neurology, 2003 - interscience.wiley.com Patients with myasthenia gravis (MG) who do not respond to conventional
immunotherapeutic agents, or cannot tolerate their side effects, are considered
refractory. Ablation of the immune system followed by bone marrow ... Cited by 71 - Related articles - BL Direct - All 5 versions
TH Brannagan III, A Pradhan, T Heiman- … - Neurology, 2002 - AAN Enterprises Four patients with chronic inflammatory demyelinating polyneuropathy (CIDP) who
were refractory to conventional treatment were treated with high-dose
cyclophosphamide (200 mg/kg over 4 days). All improved in functional status ... Cited by 43 - Related articles - BL Direct - All 4 versions
- ►hematologylibrary.org VM Moyo, D Smith, I Brodsky, P Crilley, RJ … - Blood, 2002 - bloodjournal.hematologylibrary.org High-dose cyclophosphamide was initially chosen as conditioning for allogeneic
bone marrow transplantation because of its potent immunosuppressive properties.
1 , 2 Lymphocytes are highly sensitive to cyclophosphamide, but primitive ... Cited by 33 - Related articles - BL Direct - All 5 versions
- ►hematologylibrary.org JF Tisdale, JP Maciejewski, O Nunez, SJ … - Blood, 2002 - bloodjournal.hematologylibrary.org Immunosuppression with antithymocyte globulin (ATG) and cyclosporine (CSA)
results in long-term survival in patients with severe aplastic anemia (SAA),
comparable to that achieved by allogeneic bone marrow transplantation from ... Cited by 33 - Related articles - BL Direct - All 7 versions
DE Gladstone, AA Prestrud, A Pradhan, MJ … - Lupus, 2002 - lup.sagepub.com DE Gladstone 1 *, AA Prestrud 1 , A Pradhan 1 , MJ Styler 1 , DL Topolsky 1 , PA
Crilley 1 , S Hoch 1 , A Huppert 1 and I Brodsky 1 ... 1 Drexel University,
College of Medicine, Department of Medicine, Philadelphia, PA, USA Cited by 29 - Related articles - BL Direct - All 3 versions
